期刊文献+

一种新的人血管内皮生长因子基因的剪切体(英文) 被引量:1

A probable novel splicing isoform of human vascular endothelial growth factor
下载PDF
导出
摘要 目的探索人胚胎肺组织中是否存在一种新的血管内皮生长因子(VEGF)基因可变剪切形式。方法对1例4月龄引产胎儿肺组织的总RNA进行逆转录聚合酶链反应、克隆并测定扩增片段的序列。结果用一对引物(引物5’端-21~7 bp, 3’端554~576 bp)可扩增出3条片段,一条为长度正常的VEGF165 (619 bp)全长序列,另一条为长度正常的VEGF12(1 487 bp)全长序列,第三条为新的VEGF mRNA异常剪切片段。测序检测显示,此扩增片段长度为639 bp,同样为VEGF165全长核苷酸序列,但在VEGF165的第3和第4外显子之间插入了长度为20 bp的碱基片段。序列分析显示此插入序列为滞留的第Ⅲ内含子终末序列,含内含子剪切信号。上述移码突变导致VEGF基因阅读框架发生改变,在第4外显子中游出现终止密码,故仅含VEGF165外显子1~3及4部分序列,在蛋白水平上可能编码含97个氨基酸的新肽链。结论在一引产胎儿的肺组织中发现了新的VEGF mRNA可变剪切形式,其生物学意义有待进一步研究。 Objective To characterize a new alternative splicing isoform of human vascular endothelial growth factor (VEGF) gene. Methods The total RNA was extracted from the lung tissue of a legally aborted 4-month-old fetus and amplified by RT-PCR. The amplified product was cloned into the plasmid pMD18-T and plasmid pcDNA3.1- for sequence analysis. Results Electrophoresis of the RT-PCR products displayed one short band for VEGF121 (487 bp) and a long band. The latter was characterized to contain two fragments: one was normal VEGF165 (619 bp), and the other (639 bp) had an identical nucleotide sequence to VEGF165 with a 20 bp fragment inserted between exons 3 and 4. Sequence analysis showed that this 20-bp nucleotide was inserted from the 3’ end of the third intron containing a splicing signal, thus causing shift mutation in the reading frame of VEGF gene and early appearance of the stop codon UAG in the middle of exon 4. Conclusion A new alternative splicing isoform of VEGF probably exists in the lung tissue of a legally aborted human fetus, and its biological significance remains to be further investigated.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第6期755-759,共5页 Journal of Southern Medical University
基金 Supported by Medical Scientific Research Program of PLA(01Z052) Science and Technology Research Foundation of Guangdong Province(C31206)~~
关键词 血管内皮生长因子 可变剪切形式 逆转录聚合酶链反应 vascular endothelial growth factor alternatively spliced form exons introns gene mutation
  • 相关文献

参考文献19

  • 1Clauss M. Molecular biology of the VEGF and the VEGF receptor family [J]. Semin Thromb Hemost, 2000, 26(5): 561-9.
  • 2Breier G. Functions of the VEGF/VEGF receptor system in the vascular system [J]. Semin Thromb Hemost, 2000, 26(5): 553-9.
  • 3Ferrara N. VEGFan update on biological and therapeutic aspects [J]. Curr Opin Biotechnol, 2000, 11(6): 617-24.
  • 4Wellmann S, TaubeT, Paal K, et al. Specific reverse transcription- PCR quantification of vascular endothelial growth factor (VEGF) splice variants by LightCycler technology [J]. Clin Chem, 2001, 47 (4): 654-60.
  • 5Krussel JS, Behr B, Milki A, et al. Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts [J]. Mol Hum Reprod, 2001, 7(1): 57-63.
  • 6Tischer E, Richard M, Hartman T, et al. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing [J]. J Biol Chem, 1991, 266(18): 11947-54.
  • 7Nowak DG, Woolard j, Amin EM, et al. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors [J]. J Cell Sci, 2008, 121(Pt 20): 3487-95.
  • 8Mac Gabhann F, Popel AS. Systems biology of vascular endothelial growth factors [J]. Microcirculation, 2008, 15(8): 715-38.
  • 9Grunstein J, -Masbad J, Hickey R, et ai.'Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature [J]. Mol Cell Biol, 2000, 20(19): 7282-91.
  • 10Bates DO, Harper SJ. Therapeutic potential of inhibitory VEGF splice variants |J]. Future Oncol, 2005, 1 (4): 467-73.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部